Pricing Log in Create free account

CERo Therapeutics Holdings, Inc. (CERO) vs Moolec Science SA (MLEC)

CERo Therapeutics Holdings, Inc. and Moolec Science SA are both Biotechnology companies. Moolec Science SA is the larger, with a market value of $620.0K against $140.0K — 4.4× the size. CERo Therapeutics Holdings, Inc. has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, CERo Therapeutics Holdings, Inc. leads on 6 and Moolec Science SA on 5.

Valuation

Metric CERO MLEC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.03 9.40
P/B n/m 0.01 2.13
Price to free cash flow n/m 0.01 25.18
EV/EBITDA 0.00 1.76 0.66
EV/Sales n/m 8.37 9.02
Earnings yield 0.00% (3,822.12%) (32.88%)
Free cash flow yield 0.00% 8,301.70% (23.13%)

Profitability

Metric CERO MLEC Biotechnology median
Gross margin — 2,373.25% 68.51%
Operating margin 0.00% 244.93% 0.00%
Net margin 0.00% (105.71%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 453.76% 0.00% (51.96%)
Return on assets (2,352.32%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CERO MLEC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 99.91% (793.17%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERO MLEC Biotechnology median
Debt to equity (0.02) 4.37 0.00
Current ratio 0.05 0.15 4.97
Net debt to EBITDA 0.10 (2.73) 1.01

Dividend

Metric CERO MLEC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CERO MLEC Biotechnology median
Market cap 140.00k 620.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack